Dr Boreham’s Crucible: Is this dendrimer believer on the verge of a corporate renaissance?
With Starpharma (ASX:SPL) shares having lost losing three-quarters of their value over the previous year when new CEO Cheryl Maley reported for duty on January 8 this year, the former big drug company exec knew that maintaining the status quo wouldn’t cut …